The purpose of this study is to determine whether the use of OMS302 (the study drug) in individuals undergoing Cataract Extraction with Lens Replacement (CELR) surgery is safe and effective at maintaining an adequately dilated pupil during surgery and reducing post-operative symptoms of discomfort (such as eye pain and irritation).
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Pupil Diameter (mm) During Surgery
Timeframe: During surgery (immediately prior to surgical incision to wound closure)
Ocular Pain Visual Analog Scale (VAS) Score (mm) Within 12 Hours Postoperatively
Timeframe: through 12 hours post-surgery